Loss-of-Function SCN5A Mutations Associated with Sinus Node Dysfunction, Atrial Arrhythmias, and Poor Pacemaker Capture

David Y. Chiang, Jeffrey J. Kim, Santiago O. Valdes, Caridad de la Uz, Yuxin Fan, Jeffrey Orcutt, Melissa Domino, Melissa Smith, Xander H.T. Wehrens, Christina Y. Miyake

Research output: Contribution to journalArticle

Abstract

Background - Cardiac device implantation can be complicated by inability to adequately place leads because of significant lead capture issues. This study sought to determine whether there are genetic bases that underlie poor lead capture. Methods and Results - Retrospective review of all patients with structurally normal hearts who underwent new device implantation at Texas Children's Hospital between 2009 and 2014 was performed. Patients with inability to capture at 10 V or a final capture threshold ≥3 V at 0.4 ms during implant were analyzed. Among a total of 136 patients (median age, 13 years; range, 3 days to 46 years), 11 patients (8.1%) who underwent dual chamber device implantation had elevated thresholds in the atria (4), ventricle (3), or both chambers (4; atrial-lead threshold, 4.7±4.3 versus 0.7±0.3 V; ventricular-lead, 3.0±3.3 versus 0.7±0.3 V). All 11 patients presented with sinus node dysfunction and 10 had atrial arrhythmias. At implant, inability to find atrial capture was seen in 4 patients. Three demonstrated intermittent complete loss of ventricular capture after implantation: 1 has recurrent syncope, 2 eventually died. Genetic testing performed in 10 demonstrated 7 patients with 6 distinct SCN5A mutations, all predicted to be severe loss-of-function mutations by bioinformatic analyses. In the remaining patients, although putative pathogenic mutations were not found, multiple SCN5A polymorphisms were identified in 2 and a desmin mutation in 1. Conclusions - This study suggests that significant capture issues at implant may be because of loss-of-function SCN5A mutations, providing new insights into SCN5A function. Recognition of this association may be critical for planning device implantation strategies and patient follow-up.

Original languageEnglish (US)
Pages (from-to)1105-1112
Number of pages8
JournalCirculation: Arrhythmia and Electrophysiology
Volume8
Issue number5
DOIs
StatePublished - Oct 1 2015
Externally publishedYes

Fingerprint

Sick Sinus Syndrome
Cardiac Arrhythmias
Mutation
Equipment and Supplies
Desmin
Syncope
Genetic Testing
Computational Biology

Keywords

  • atrial tachyarrhythmia with short PR
  • Brugada syndrome
  • cardiac pacemaker, artificial
  • implantable cardioverter-defibrillators
  • NaV1.5 voltage-gated sodium channel
  • SCN5A protein, human
  • sick sinus syndrome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Loss-of-Function SCN5A Mutations Associated with Sinus Node Dysfunction, Atrial Arrhythmias, and Poor Pacemaker Capture. / Chiang, David Y.; Kim, Jeffrey J.; Valdes, Santiago O.; de la Uz, Caridad; Fan, Yuxin; Orcutt, Jeffrey; Domino, Melissa; Smith, Melissa; Wehrens, Xander H.T.; Miyake, Christina Y.

In: Circulation: Arrhythmia and Electrophysiology, Vol. 8, No. 5, 01.10.2015, p. 1105-1112.

Research output: Contribution to journalArticle

Chiang, David Y. ; Kim, Jeffrey J. ; Valdes, Santiago O. ; de la Uz, Caridad ; Fan, Yuxin ; Orcutt, Jeffrey ; Domino, Melissa ; Smith, Melissa ; Wehrens, Xander H.T. ; Miyake, Christina Y. / Loss-of-Function SCN5A Mutations Associated with Sinus Node Dysfunction, Atrial Arrhythmias, and Poor Pacemaker Capture. In: Circulation: Arrhythmia and Electrophysiology. 2015 ; Vol. 8, No. 5. pp. 1105-1112.
@article{51f028b39f0c42e986cc53cf567a2faa,
title = "Loss-of-Function SCN5A Mutations Associated with Sinus Node Dysfunction, Atrial Arrhythmias, and Poor Pacemaker Capture",
abstract = "Background - Cardiac device implantation can be complicated by inability to adequately place leads because of significant lead capture issues. This study sought to determine whether there are genetic bases that underlie poor lead capture. Methods and Results - Retrospective review of all patients with structurally normal hearts who underwent new device implantation at Texas Children's Hospital between 2009 and 2014 was performed. Patients with inability to capture at 10 V or a final capture threshold ≥3 V at 0.4 ms during implant were analyzed. Among a total of 136 patients (median age, 13 years; range, 3 days to 46 years), 11 patients (8.1{\%}) who underwent dual chamber device implantation had elevated thresholds in the atria (4), ventricle (3), or both chambers (4; atrial-lead threshold, 4.7±4.3 versus 0.7±0.3 V; ventricular-lead, 3.0±3.3 versus 0.7±0.3 V). All 11 patients presented with sinus node dysfunction and 10 had atrial arrhythmias. At implant, inability to find atrial capture was seen in 4 patients. Three demonstrated intermittent complete loss of ventricular capture after implantation: 1 has recurrent syncope, 2 eventually died. Genetic testing performed in 10 demonstrated 7 patients with 6 distinct SCN5A mutations, all predicted to be severe loss-of-function mutations by bioinformatic analyses. In the remaining patients, although putative pathogenic mutations were not found, multiple SCN5A polymorphisms were identified in 2 and a desmin mutation in 1. Conclusions - This study suggests that significant capture issues at implant may be because of loss-of-function SCN5A mutations, providing new insights into SCN5A function. Recognition of this association may be critical for planning device implantation strategies and patient follow-up.",
keywords = "atrial tachyarrhythmia with short PR, Brugada syndrome, cardiac pacemaker, artificial, implantable cardioverter-defibrillators, NaV1.5 voltage-gated sodium channel, SCN5A protein, human, sick sinus syndrome",
author = "Chiang, {David Y.} and Kim, {Jeffrey J.} and Valdes, {Santiago O.} and {de la Uz}, Caridad and Yuxin Fan and Jeffrey Orcutt and Melissa Domino and Melissa Smith and Wehrens, {Xander H.T.} and Miyake, {Christina Y.}",
year = "2015",
month = "10",
day = "1",
doi = "10.1161/CIRCEP.115.003098",
language = "English (US)",
volume = "8",
pages = "1105--1112",
journal = "Circulation: Arrhythmia and Electrophysiology",
issn = "1941-3149",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Loss-of-Function SCN5A Mutations Associated with Sinus Node Dysfunction, Atrial Arrhythmias, and Poor Pacemaker Capture

AU - Chiang, David Y.

AU - Kim, Jeffrey J.

AU - Valdes, Santiago O.

AU - de la Uz, Caridad

AU - Fan, Yuxin

AU - Orcutt, Jeffrey

AU - Domino, Melissa

AU - Smith, Melissa

AU - Wehrens, Xander H.T.

AU - Miyake, Christina Y.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background - Cardiac device implantation can be complicated by inability to adequately place leads because of significant lead capture issues. This study sought to determine whether there are genetic bases that underlie poor lead capture. Methods and Results - Retrospective review of all patients with structurally normal hearts who underwent new device implantation at Texas Children's Hospital between 2009 and 2014 was performed. Patients with inability to capture at 10 V or a final capture threshold ≥3 V at 0.4 ms during implant were analyzed. Among a total of 136 patients (median age, 13 years; range, 3 days to 46 years), 11 patients (8.1%) who underwent dual chamber device implantation had elevated thresholds in the atria (4), ventricle (3), or both chambers (4; atrial-lead threshold, 4.7±4.3 versus 0.7±0.3 V; ventricular-lead, 3.0±3.3 versus 0.7±0.3 V). All 11 patients presented with sinus node dysfunction and 10 had atrial arrhythmias. At implant, inability to find atrial capture was seen in 4 patients. Three demonstrated intermittent complete loss of ventricular capture after implantation: 1 has recurrent syncope, 2 eventually died. Genetic testing performed in 10 demonstrated 7 patients with 6 distinct SCN5A mutations, all predicted to be severe loss-of-function mutations by bioinformatic analyses. In the remaining patients, although putative pathogenic mutations were not found, multiple SCN5A polymorphisms were identified in 2 and a desmin mutation in 1. Conclusions - This study suggests that significant capture issues at implant may be because of loss-of-function SCN5A mutations, providing new insights into SCN5A function. Recognition of this association may be critical for planning device implantation strategies and patient follow-up.

AB - Background - Cardiac device implantation can be complicated by inability to adequately place leads because of significant lead capture issues. This study sought to determine whether there are genetic bases that underlie poor lead capture. Methods and Results - Retrospective review of all patients with structurally normal hearts who underwent new device implantation at Texas Children's Hospital between 2009 and 2014 was performed. Patients with inability to capture at 10 V or a final capture threshold ≥3 V at 0.4 ms during implant were analyzed. Among a total of 136 patients (median age, 13 years; range, 3 days to 46 years), 11 patients (8.1%) who underwent dual chamber device implantation had elevated thresholds in the atria (4), ventricle (3), or both chambers (4; atrial-lead threshold, 4.7±4.3 versus 0.7±0.3 V; ventricular-lead, 3.0±3.3 versus 0.7±0.3 V). All 11 patients presented with sinus node dysfunction and 10 had atrial arrhythmias. At implant, inability to find atrial capture was seen in 4 patients. Three demonstrated intermittent complete loss of ventricular capture after implantation: 1 has recurrent syncope, 2 eventually died. Genetic testing performed in 10 demonstrated 7 patients with 6 distinct SCN5A mutations, all predicted to be severe loss-of-function mutations by bioinformatic analyses. In the remaining patients, although putative pathogenic mutations were not found, multiple SCN5A polymorphisms were identified in 2 and a desmin mutation in 1. Conclusions - This study suggests that significant capture issues at implant may be because of loss-of-function SCN5A mutations, providing new insights into SCN5A function. Recognition of this association may be critical for planning device implantation strategies and patient follow-up.

KW - atrial tachyarrhythmia with short PR

KW - Brugada syndrome

KW - cardiac pacemaker, artificial

KW - implantable cardioverter-defibrillators

KW - NaV1.5 voltage-gated sodium channel

KW - SCN5A protein, human

KW - sick sinus syndrome

UR - http://www.scopus.com/inward/record.url?scp=84944687596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944687596&partnerID=8YFLogxK

U2 - 10.1161/CIRCEP.115.003098

DO - 10.1161/CIRCEP.115.003098

M3 - Article

C2 - 26111534

AN - SCOPUS:84944687596

VL - 8

SP - 1105

EP - 1112

JO - Circulation: Arrhythmia and Electrophysiology

JF - Circulation: Arrhythmia and Electrophysiology

SN - 1941-3149

IS - 5

ER -